ArticleJournal of molecular neuroscience : MN2025
Vascular Cell Adhesion Molecule-1 and Complement C3 involvement in Febrile Seizures in Children.
Article in Journal of molecular neuroscience : MN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Elevated inflammation, characterized by increased proinflammatory cytokine levels in febrile seizures (FSs), has been well documented; however, the underlying causes and contributing factors remain unclear. This study aimed to investigate the molecular components that may contribute to or protect against inflammation in children with FS. The study involved children aged 6-60 months with FS (FS group, n = 29), afebrile seizures (AS group, n = 17), and febrile controls (FC group, n = 30). Leukocyte count, C-reactive protein, complement C3 and C4, fibrinogen, intercellular and vascular cell adhesion molecules (ICAM-1, VCAM-1), adrenocorticotropic hormone (ACTH), and cortisol levels were measured at onset (T1) and 24 h later (T2) in the seizure groups and at T1 in the FC group, whose samples served as controls for both periods alongside the AS group. At T2 time compared with T1, VCAM-1 levels increased and C3 levels decreased in the FS group, whereas ICAM-1 levels increased in the AS group (p = 0.001, p = 0.048, p = 0.035, respectively). The FS and AS groups had higher leukocyte counts at T1 than T2 (p < 0.001, p = 0.023, respectively). The FS group had higher cortisol levels than the AS group and higher ACTH levels than the FC group at T1 (p < 0.001, p = 0.037, respectively), but at T2, the FS group had lower ACTH levels than the AS and FC groups (p = 0.037, p = 0.006, respectively). In conclusion, VCAM-1 and C3 alterations observed in FS suggest their involvement in inflammation, possibly related to leukocyte migration. Additionally, a higher ACTH peak after FS may be associated with a more benign profile compared with epilepsy.
Indexed as
Identifiers
40632197What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.